Abstract:The increase in bacterial resistance to antibiotics has led researchers to find new compounds or find combinations between different compounds with potential antibacterial action and with the ability to prevent the development of antibiotic resistance. Polyoxotungstates (POTs) are inorganic clusters that may fulfill that need, either individually or in combination with antibiotics. Herein, we report the ability of the polyoxotungstates (POTs) with Wells-Dawson P2W18, P2W17, P2W15, and Preyssler P5W30 type structures to differently affect Gram-negative and Gram-positive microorganisms, either susceptible or resistant to antibiotics. The compound P5W30 showed the highest activity against the majority of the tested bacterial strains in comparison with the other tested POTs (P2W15, P2W17 and P2W18) that did not show inhibition zones for the Gram-negative bacteria, A. baumanii I73775, E. coli DSM 1077, E. coli I73194, K. pneumoniae I7092374, and P. aeruginosa C46281). Generally, the results evidenced that Gram-positive bacteria are more susceptible to the POTs tested. The compound P5W30 was the one most active against S. aureus ATCC 6538 and MRSA 16, reaching <0.83 mg·mL−1 (100 μM) and 4.96 mg·mL−1 (600 μM), respectively. Moreover, it was verified by NMR spectroscopy that the most promising POT, P5W30, remains intact under all the experimental conditions, after 24 h at 37 °C. This prompted us to further evaluate the anti-quorum sensing activity of P5W30 using the biosensor Chromobacterium violaceum CV026, as well as its antibiofilm activity both individually and in combination with the antibiotic cefoxitin against the methicillin-resistant Staphylococcus aureus 16 (MRSA16). P5W30 showed a synergistic antibacterial effect with the antibiotic cefoxitin and chloramphenicol against MRSA 16. Moreover, the antibiofilm activity of P5W30 was more pronounced when used individually, in comparison with the combination with the antibiotic cefoxitin. Finally, the antiviral activity of P5W30 was tested using the coliphage Qβ, showing a dose-dependent response. The maximum inactivation was observed at 750 μM (6.23 mg·mL−1). In sum, P5W30 shows anti-quorum sensing and antibiofilm activities besides being a potent antibacterial agent against S. aureus and to exhibit antiviral activities against enteric viruses.

Unveiling the agonistic properties of Preyssler-type Polyoxotungstates on purinergic P2 receptors

The Purinergic Agonists Atp and Utp Act Predominantly Via P2y Receptors in Human Vascular Endothelial Cells

Purinergic P2Y2 receptors mediate rapid Ca2+ mobilization, membrane hyperpolarization and nitric oxide production in human vascular endothelial cells

The Preyssler-Type Polyoxotungstate Exhibits Anti-Quorum Sensing, Antibiofilm, and Antiviral Activities

Experimental observation of the role of countercations on the electrical conductance of Preyssler-type polyoxometalate nanodevices

Expression and function of P2X purinoceptors in rat histaminergic neurons

Ionotropic purinergic receptor 7 (P2X7) channel structure and pharmacology provides insight regarding non-nucleotide agonism

Structural insights into the orthosteric inhibition of P2X receptors by non-ATP analog antagonists

Functional characterisation of P2 purinoceptors in PC12 cells by measurement of radiolabelled calcium influx

Modulation of P2X7 receptor functions by polymyxin B: crucial role of the hydrophobic tail of the antibiotic molecule

The P2X<sub>1</sub>ion channel in platelet function

Molecular Mechanisms of Human P2X3 Receptor Channel Activation and Modulation by Divalent Cation Bound ATP

Differential effects of uridine adenosine tetraphosphateon purinoceptors in the rat isolated perfused kidney

Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists

Subtype-Specific Ligand Binding and Activation Gating in Homomeric and Heteromeric P2X Receptors

Structural insights into the orthosteric inhibition of P2X receptors by non-ATP-analog antagonists

Preparation and preliminary evaluation of a tritium-labeled allosteric P2X4 receptor antagonist

P2 Receptor Expression Profiles in Human Vascular Smooth Muscle and Endothelial Cells

Discovery of Triazolopyrimidine Derivatives as Selective P2X3 Receptor Antagonists Binding to an Unprecedented Allosteric Site as Evidenced by Cryo-Electron Microscopy

A Second Drug Binding Site in P2X3

Studies towards the development of a PET radiotracer for imaging of the P2Y1 receptors in the brain: synthesis, 18F-labeling and preliminary biological evaluation